A decade ago, designing cancer treatment around an individual’s genetic profile was largely aspirational. Precision oncology — driven by immunotherapies, targeted biologics and cell and gene therapies — is now becoming standard practice.
These targeted innovations bring new clinical possibilities and a corresponding increase in complexity across the care journey. Meeting that complexity requires ongoing advances in science, logistics and patient support as therapies move from clinical development to approval and real-world use.
McKesson says realizing the full promise of precision oncology requires an ecosystem that connects biopharma manufacturers, providers, payers and patients. The company has built infrastructure in specialty logistics, specialty pharmacy and patient support aimed at expanding access, especially in community settings where most patients receive care.
McKesson’s services span development, commercialization and distribution. Its approach focuses on integrating services so patients navigating genetic testing, insurance authorizations and care coordination receive timely, cohesive support.
Through Biologics by McKesson, the company provides specialty pharmacy solutions tailored to patients receiving advanced therapies. Services include education and counseling, benefits investigation, prior authorization assistance, infusion coordination and adherence support to help patients start and stay on therapy.
To support cell and gene therapies, Biologics and InspiroGene launched InspiroCare, a dedicated hub offering concierge-style assistance. InspiroCare coordinates with providers, manages insurance and logistics, and guides patients and caregivers through the treatment pathway to reduce access barriers.
McKesson and The US Oncology Network collaborate on Precision Care Companion (PCC) to help community oncology practices adopt biomarker-directed therapies. PCC provides targeted education, technology enhancements, operational best practices and analytics on biomarker testing rates by cancer type to support routine use of precision care.
By combining logistics, specialty pharmacy, patient support and practice solutions, McKesson aims to make precision medicine not only a scientific advance but a reliable and accessible standard of care across communities.
Leave a Reply